Playback speed
10 seconds
2021 ASCO Updates on KEYLYNK-013 Study for Newly Diagnosed LS-SCLC: Pembro+CCRT Followed by Pembro +/- Olaparib vs. CCRT
By
Memorial Sloan Kettering Cancer Center
FEATURING
Andreas Rimner
By
Memorial Sloan Kettering Cancer Center
FEATURING
Andreas Rimner
240 views
June 16, 2021
Login to view comments.
Click here to Login